vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Service Properties Trust (SVC). Click either name above to swap in a different company.

Service Properties Trust is the larger business by last-quarter revenue ($296.5M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). Service Properties Trust runs the higher net margin — -0.3% vs -82.0%, a 81.7% gap on every dollar of revenue. On growth, Service Properties Trust posted the faster year-over-year revenue change (-17.0% vs -22.7%). PTC THERAPEUTICS, INC. produced more free cash flow last quarter ($-36.6M vs $-95.2M). Over the past eight quarters, Service Properties Trust's revenue compounded faster (-6.1% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

PTCT vs SVC — Head-to-Head

Bigger by revenue
SVC
SVC
1.8× larger
SVC
$296.5M
$164.7M
PTCT
Growing faster (revenue YoY)
SVC
SVC
+5.8% gap
SVC
-17.0%
-22.7%
PTCT
Higher net margin
SVC
SVC
81.7% more per $
SVC
-0.3%
-82.0%
PTCT
More free cash flow
PTCT
PTCT
$58.5M more FCF
PTCT
$-36.6M
$-95.2M
SVC
Faster 2-yr revenue CAGR
SVC
SVC
Annualised
SVC
-6.1%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
SVC
SVC
Revenue
$164.7M
$296.5M
Net Profit
$-135.0M
$-782.0K
Gross Margin
Operating Margin
-43.3%
-3.9%
Net Margin
-82.0%
-0.3%
Revenue YoY
-22.7%
-17.0%
Net Profit YoY
-104.8%
99.0%
EPS (diluted)
$-1.63
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SVC
SVC
Q4 25
$164.7M
$296.5M
Q3 25
$211.0M
$377.6M
Q2 25
$178.9M
$404.4M
Q1 25
$1.2B
$335.0M
Q4 24
$213.2M
$357.0M
Q3 24
$196.8M
$390.9M
Q2 24
$186.7M
$412.5M
Q1 24
$210.1M
$336.2M
Net Profit
PTCT
PTCT
SVC
SVC
Q4 25
$-135.0M
$-782.0K
Q3 25
$15.9M
$-46.9M
Q2 25
$-64.8M
$-38.2M
Q1 25
$866.6M
$-116.4M
Q4 24
$-65.9M
$-76.4M
Q3 24
$-106.7M
$-46.9M
Q2 24
$-99.2M
$-73.8M
Q1 24
$-91.6M
$-78.4M
Operating Margin
PTCT
PTCT
SVC
SVC
Q4 25
-43.3%
-3.9%
Q3 25
1.4%
-12.8%
Q2 25
-19.5%
-9.2%
Q1 25
82.5%
-33.3%
Q4 24
-76.2%
-19.4%
Q3 24
-27.7%
-12.8%
Q2 24
-21.5%
-17.1%
Q1 24
-21.6%
-21.4%
Net Margin
PTCT
PTCT
SVC
SVC
Q4 25
-82.0%
-0.3%
Q3 25
7.5%
-12.4%
Q2 25
-36.3%
-9.4%
Q1 25
73.7%
-34.8%
Q4 24
-30.9%
-21.4%
Q3 24
-54.2%
-12.0%
Q2 24
-53.1%
-17.9%
Q1 24
-43.6%
-23.3%
EPS (diluted)
PTCT
PTCT
SVC
SVC
Q4 25
$-1.63
$-0.01
Q3 25
$0.20
$-0.28
Q2 25
$-0.83
$-0.23
Q1 25
$10.04
$-0.70
Q4 24
$-0.85
$-0.46
Q3 24
$-1.39
$-0.28
Q2 24
$-1.29
$-0.45
Q1 24
$-1.20
$-0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SVC
SVC
Cash + ST InvestmentsLiquidity on hand
$1.9B
$346.8M
Total DebtLower is stronger
$5.5B
Stockholders' EquityBook value
$-205.3M
$646.1M
Total Assets
$2.9B
$6.5B
Debt / EquityLower = less leverage
8.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SVC
SVC
Q4 25
$1.9B
$346.8M
Q3 25
$1.7B
$417.4M
Q2 25
$2.0B
$63.2M
Q1 25
$2.0B
$80.1M
Q4 24
$1.1B
$143.5M
Q3 24
$1.0B
$48.6M
Q2 24
$1.1B
$14.6M
Q1 24
$884.8M
$71.3M
Total Debt
PTCT
PTCT
SVC
SVC
Q4 25
$5.5B
Q3 25
Q2 25
Q1 25
Q4 24
$5.8B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PTCT
PTCT
SVC
SVC
Q4 25
$-205.3M
$646.1M
Q3 25
$-155.8M
$647.9M
Q2 25
$-206.5M
$695.9M
Q1 25
$-185.8M
$734.6M
Q4 24
$-1.1B
$851.9M
Q3 24
$-1.1B
$929.0M
Q2 24
$-980.2M
$1.0B
Q1 24
$-893.9M
$1.1B
Total Assets
PTCT
PTCT
SVC
SVC
Q4 25
$2.9B
$6.5B
Q3 25
$2.6B
$7.0B
Q2 25
$2.6B
$6.9B
Q1 25
$2.7B
$7.0B
Q4 24
$1.7B
$7.1B
Q3 24
$1.8B
$7.1B
Q2 24
$1.9B
$7.1B
Q1 24
$1.8B
$7.2B
Debt / Equity
PTCT
PTCT
SVC
SVC
Q4 25
8.52×
Q3 25
Q2 25
Q1 25
Q4 24
6.85×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SVC
SVC
Operating Cash FlowLast quarter
$-34.3M
$-18.5M
Free Cash FlowOCF − Capex
$-36.6M
$-95.2M
FCF MarginFCF / Revenue
-22.3%
-32.1%
Capex IntensityCapex / Revenue
1.4%
25.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$-107.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SVC
SVC
Q4 25
$-34.3M
$-18.5M
Q3 25
$-66.3M
$98.1M
Q2 25
$-58.3M
$-7.0K
Q1 25
$870.1M
$38.2M
Q4 24
$-30.0M
$-9.7M
Q3 24
$-77.0M
$106.2M
Q2 24
$-71.5M
$43.8M
Q1 24
$70.8M
$-926.0K
Free Cash Flow
PTCT
PTCT
SVC
SVC
Q4 25
$-36.6M
$-95.2M
Q3 25
$-69.7M
$57.9M
Q2 25
$-59.6M
$-46.6M
Q1 25
$868.4M
$-23.2M
Q4 24
$-33.8M
$-88.9M
Q3 24
$-77.5M
$24.1M
Q2 24
$-78.8M
$-22.3M
Q1 24
$61.2M
$-77.2M
FCF Margin
PTCT
PTCT
SVC
SVC
Q4 25
-22.3%
-32.1%
Q3 25
-33.1%
15.3%
Q2 25
-33.3%
-11.5%
Q1 25
73.8%
-6.9%
Q4 24
-15.8%
-24.9%
Q3 24
-39.4%
6.2%
Q2 24
-42.2%
-5.4%
Q1 24
29.1%
-23.0%
Capex Intensity
PTCT
PTCT
SVC
SVC
Q4 25
1.4%
25.9%
Q3 25
1.6%
10.6%
Q2 25
0.7%
11.5%
Q1 25
0.1%
18.3%
Q4 24
1.8%
22.2%
Q3 24
0.3%
21.0%
Q2 24
4.0%
16.0%
Q1 24
4.6%
22.7%
Cash Conversion
PTCT
PTCT
SVC
SVC
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons